![]()
Previously known as: PEPTECH LIMITED (PTD)
ASX code: AAH
Listing Date: Thu, 23 Jan 1986
Website: http://www.arana.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
An international biopharmaceutical company focussed on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer.
Address:
37 Epping Road, Level 2
MACQUARIE PARK
NSW 2113
Phone: 02 8061 9900
Fax: 02 8061 9999
Executives & Directors
Mr Robin Beaumont, Chairman
Dr John Chiplin, Managing Director, CEO
Dr George Jessup, Director
Dr Lincoln Chee, Non Exec. Director
Mr Chris Harris, Independent Director, Non Exec. Director
Mr Niall Henderson, CFO
Please contact the ASX to change these details
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
View this company's details on the Australian Securities Exchange website
ARANA THERAPEUTICS LIMITED (AAH) Events
ARANA THERAPEUTICS LIMITED (AAH)
| Arana Completes a Series of Antibodies for Vegenics | Thu, 2 Oct 2008 |
| CIR: Arana completes humanisation of antibody for Vegenics | Thu, 2 Oct 2008 |
| Arana Files IND for Lead Anti-Inflammatory Product ART621 | Tue, 30 Sep 2008 |
| Corporate presentation - clarification | Thu, 25 Sep 2008 |
| Arana presentation | Tue, 23 Sep 2008 |
| Arana Updates Inflammatory Pipeline Milestones | Mon, 22 Sep 2008 |
| Becoming a substantial holder | Mon, 8 Sep 2008 |
| Arana Announces Key Anti-Inflammatory Drug Milestone | Thu, 28 Aug 2008 |
| Arana news - August 2008 | Mon, 18 Aug 2008 |
| Results of Meeting | Wed, 13 Aug 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.























